Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
Status:
Completed
Trial end date:
2009-12-21
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known if combination chemotherapy is more effective
than no further treatment for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of vinorelbine plus
cisplatin with that of no further therapy in treating patients who have stage I or stage II
non-small cell lung cancer that has been completely removed during surgery.
Phase:
Phase 3
Details
Lead Sponsor:
NCIC Clinical Trials Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI) Southwest Oncology Group